Acumetis appoints Ramil Burden as Chief Executive Officer
Founder and CEO Brent Herspiegel to retire and continue serving on the Board of Directors
- Acumetis appoints Ramil Burden as Chief Executive Officer, effective September 14, 2026
- Founder and CEO Brent Herspiegel steps down from the CEO role and moves to the company’s Board of Directors, supporting a smooth transition. Herspiegel will continue to support the business from the Board, drawing on his founder’s experience and long-standing client relationships
- Burden joins with over two decades of leadership experience in pharmaceutical, healthcare and life sciences, including as CEO of Optum Life Sciences and 17 years at GSK
- The appointment marks the next chapter for Acumetis as it continues to help life sciences organizations accelerate growth and strengthen commercial performance
Yardley, PA, [September 24, 2026] – Acumetis today announced the appointment of Ramil Burden as Chief Executive Officer, effective September 14, 2026. Founder and CEO Brent Herspiegel will retire from the CEO role and continue serving on the company’s Board of Directors, helping ensure a seamless transition and supporting the company’s long-term success.
For more than two decades, Acumetis has partnered with life sciences innovators to help bring transformative therapies to market and improve lives. Guided by a belief that great science deserves great commercialization, the company helps clients reframe what’s possible by challenging assumptions, connecting insight across the asset lifecycle, and turning complexity into clearer, more confident decisions.
Today, Acumetis serves pharmaceutical, biotechnology, and healthcare organizations around the world, helping them navigate increasingly complex commercialization challenges while accelerating growth, strengthening brand performance, and maximizing the impact of healthcare innovation.
“What has always inspired me most about Acumetis is the impact we help our clients create,” said Herspiegel. “We have built a company grounded in expertise, entrepreneurial thinking, and a deep commitment to client success. By bringing together diverse perspectives, connected thinking, and practical innovation, we help life sciences leaders make better decisions and achieve better outcomes. Ramil is the right leader to build on that foundation and help our clients capture the opportunities ahead.”
Burden brings more than two decades of leadership experience across the pharmaceutical, healthcare, and life sciences sectors, including serving as Chief Executive Officer of Optum Life Sciences and holding senior commercial, strategy, and leadership roles during a 17-year career at GSK. He has a proven track record of scaling businesses, strengthening execution, and creating lasting value for clients, patients, and stakeholders.
“This is an exciting time for healthcare and for Acumetis,” said Burden. “Scientific advances are opening new possibilities for patients around the world, while increasing complexity is raising the stakes for every commercial decision. Acumetis stands apart in its ability to connect expertise across disciplines, reveal new opportunities, and translate insight into action. I am honored to join this exceptional team and excited to help our clients bring important therapies to market faster, achieve stronger brand performance, and realize the full potential of their innovations.”
Under Burden’s leadership, Acumetis will continue investing in the talent, technology, and connected capabilities that enable clients to see differently, decide confidently, and act decisively. Supported by an experienced executive leadership team and senior experts across the business, the company enters this next chapter from a position of strength, helping life sciences organizations de-risk execution, accelerate performance, and unlock the full potential of their medicines and innovations.
“The future belongs to organizations that can transform possibility into impact,” added Herspiegel. “Acumetis has built an exceptional team, strong client partnerships, and a culture centered on helping our clients succeed. I am incredibly optimistic about what lies ahead and confident that Acumetis is uniquely positioned to help shape the future of healthcare commercialization.”
About Acumetis
Acumetis is a global life sciences commercialization partner built to reframe what’s possible. By connecting expertise across medical, access, commercial, evidence, insights, analytics, and patient strategy, Acumetis helps clients challenge assumptions, sharpen decisions, and translate scientific innovation into measurable outcomes. Through a combination of deep industry experience, practical innovation, and integrated thinking, Acumetis helps life sciences organizations accelerate market success and improve outcomes for the patients they serve.
Media Contact
Melanie Parkinson
Senior Brand & Communication Manager
Acumetis
media@acumetisglobal.com